In this blog, we have provided tips to perform effective post-market surveillance under EU-MDR. What is post-market surveillance under EU-MDR? Post-market surveillance under EU-MDR is the structured process by which manufacturers continuously monitor the safety,...
Navigating EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) is proving to be one of the most complex regulatory challenges for manufacturers. We have presented some of the common EU MDR compliance challenges. Additionally, we have provided...
Common EU MDR pitfalls are recurring mistakes and compliance gaps that medical device manufacturers encounter when implementing EU MDR. These compliance gaps frequently lead to delays in obtaining CE marking, and rejection by Notified Bodies. The transition from the...
EU MDR General Safety and Performance Requirements (GSPR) have recently been updated. The latest changes in EU MDR GSPR have introduced stricter expectations around cybersecurity, clinical evidence, environmental impact, and AI/ML devices. While core compliance areas,...
Legacy devices are products that were legally certified under older directives (MDD) but are allowed to remain in EU market. The EU MDR has released new guidelines for legacy devices. Legacy devices will have to mandatorily comply with these guidelines to...